These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3264816)

  • 1. [A possible visceralization in a case of cutaneous T cell lymphoma under treatment with recombinant interferon alfa 2].
    Tulli A; Biele MM; Capizzi R
    G Ital Dermatol Venereol; 1988 May; 123(5):262. PubMed ID: 3264816
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of cutaneous T cell lymphoma treated with recombinant interleukin 2 (rIL-2).
    Nagatani T; Kin ST; Baba N; Miyamoto H; Nakajima H; Katoh Y
    Acta Derm Venereol; 1988; 68(6):504-8. PubMed ID: 2467489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heterogenicity of T-cell cutaneous lymphomas: pleomorphic lymphoma of intermediate phenotype between the thymic and post-thymic stages. Study of 2 cases].
    Bernengo MG; Musso L; Novelli M; Doveil GC
    G Ital Dermatol Venereol; 1987 Apr; 122(4):157-66. PubMed ID: 3497094
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of cutaneous lymphoma of T-cell type with preceding benign cutaneous lesions over two years (author's transl)].
    Nasu K; Tatsumi E; Takiuchi Y; Shirakawa S; Uchino H; Ohtsuki H
    Rinsho Ketsueki; 1981 Jun; 22(6):917-24. PubMed ID: 6977656
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic effect of human lymphoblastoid interferon (MOR-22) on malignant skin tumors--a phase II study].
    Mishima Y
    Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):1059-67. PubMed ID: 3760649
    [No Abstract]   [Full Text] [Related]  

  • 6. Low dosage alpha-interferon treatment in patients with advanced cutaneous T-cell lymphoma.
    Hagberg H; Juhlin L; Scheynius A; Tjernlund U
    Eur J Haematol; 1988 Jan; 40(1):31-4. PubMed ID: 3277854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic options in advanced cutaneous T cell lymphomas: a role for interferon alfa-2a (Roferon-A).
    Bunn PA; Foon KA
    Semin Oncol; 1985 Dec; 12(4 Suppl 5):18-24. PubMed ID: 3878594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignant angioendotheliomatosis or intravascular lymphoma/angiotropic lymphoma].
    Schubert B
    Ann Dermatol Venereol; 1990; 117(3):221-3. PubMed ID: 2193592
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mycosis fungoides and lymphomatoid papulosis].
    Wallach D; Janier M; Lechanteur C; Vignon-Pennamen MD; Flageul B; Cottenot F
    Ann Dermatol Venereol; 1984; 111(8):773-4. PubMed ID: 6335634
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of T-cell malignant lymphoma with huge thin-walled cavities in the lung after chemotherapy].
    Yamaguchi E; Okazaki N; Tsuji M; Abe S; Kawakami Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Oct; 22(10):939-43. PubMed ID: 6335735
    [No Abstract]   [Full Text] [Related]  

  • 11. [Primary cutaneous lymphoma].
    Parra R; Bernado L; García-Bragado F; Serrano A; Camp L; Villar M; Vilardell M
    Med Clin (Barc); 1984 Apr; 82(13):589-91. PubMed ID: 6374314
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha-2 interferon therapy for cutaneous T cell lymphoma.
    Tulli A
    J Am Acad Dermatol; 1989 Apr; 20(4):686-7. PubMed ID: 2785538
    [No Abstract]   [Full Text] [Related]  

  • 13. [Local application of interferon beta to skin lesions of malignant melanoma and malignant lymphoma--clinical and histopathological analysis].
    Ito Y; Jimbow K; Miura S; Maeda K
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1263-8. PubMed ID: 6732253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
    Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
    Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cutaneous T cell lymphoma with intermediate doses of interferon alpha 2a.
    Nicolas JF; Balblanc JC; Frappaz A; Chouvet B; Delcombel M; Thivolet J
    Dermatologica; 1989; 179(1):34-7. PubMed ID: 2767295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surface marker and clinical diversity in cutaneous T cell lymphoma (CTCL): a case showing spontaneous regression and double marker].
    Maeda K; Yamana K; Jimbow K
    Nihon Hifuka Gakkai Zasshi; 1987 Aug; 97(9):1007-13. PubMed ID: 3501489
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous T-lymphocyte lymphoma in association with multiple myeloma.
    Weiss VC; Barsky GJ; Solomon LM
    Arch Dermatol; 1984 Apr; 120(4):499-501. PubMed ID: 6608320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pagetoid lymphoma of the Ketron-Goodman type].
    Royer P; Bagot M; Wechsler J; Roujeau JC; Fraitag S; Revuz J
    Ann Dermatol Venereol; 1989; 116(11):883-4. PubMed ID: 2619196
    [No Abstract]   [Full Text] [Related]  

  • 19. Cisplatin treatment of cutaneous T-cell lymphoma.
    Witman G; Cadman E; Braverman I
    Cancer Treat Rep; 1981; 65(9-10):920. PubMed ID: 6974043
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous T-cell lymphoma.
    Guarino MJ
    Del Med J; 1989 Sep; 61(9):447-52. PubMed ID: 2612702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.